Bertino G - Search Results

1

Systemic therapies in hepatocellular carcinoma: present and future.

Bertino G, Di Carlo I, Ardiri A, Calvagno GS, Demma S, Malaguarnera G, Bertino N, Malaguarnera M, Toro A, Malaguarnera M. Bertino G, et al. Among authors: bertino n. Future Oncol. 2013 Oct;9(10):1533-48. doi: 10.2217/fon.13.171. Future Oncol. 2013. PMID: 24106903 Review.

2

Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.

Neri S, Pulvirenti D, Malaguarnera M, Cosimo BM, Bertino G, Ignaccolo L, Siringo S, Castellino P. Neri S, et al. Among authors: bertino g. Dig Dis Sci. 2008 Mar;53(3):830-5. doi: 10.1007/s10620-007-9919-9. Epub 2007 Oct 16. Dig Dis Sci. 2008. PMID: 17939047

3

Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis.

Bertino G, Ardiri AM, Boemi P, Bruno CM, Valenti M, Mazzarino MC, Consolo M, Calvagno GS, Pulvirenti D, Neri S. Bertino G, et al. Minerva Gastroenterol Dietol. 2007 Dec;53(4):305-9. Minerva Gastroenterol Dietol. 2007. PMID: 18043548

4

Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria.

Bruno CM, Valenti M, Bertino G, Ardiri A, Bruno F, Cunsolo M, Pulvirenti D, Neri S. Bruno CM, et al. Among authors: bertino g. Minerva Med. 2008 Feb;99(1):1-5. Minerva Med. 2008. PMID: 18299691

5

A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.

Bertino G, Ardiri AM, Boemi PM, Ierna D, Interlandi D, Caruso L, Minona E, Trovato MA, Vicari S, Li Destri G, Puleo S. Bertino G, et al. Panminerva Med. 2008 Sep;50(3):221-6. Panminerva Med. 2008. PMID: 18927526

6

Some patients with HCC haven't abnornormal des-gamma-carboxy prothrombin and alpha-fetoprotein levels.

Bertino G, Ardiri AM, Santonocito MM, Boemi PM. Bertino G, et al. Panminerva Med. 2009 Jun;51(2):133-4. Panminerva Med. 2009. PMID: 19776714 No abstract available.

7

In chronic viral hepatitis without malignancy, abnormal serum carbohydrate 19-9 antigen levels are associated with liver disease severity and are related to different viral aetiology.

Bertino G, Ardiri AM, Calvagno GS, Boemi PM. Bertino G, et al. Dig Liver Dis. 2010 Jun;42(6):458-9. doi: 10.1016/j.dld.2009.09.011. Epub 2009 Oct 31. Dig Liver Dis. 2010. PMID: 19880358 No abstract available.

8

Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features.

Bruno CM, Valenti M, Bertino G, Ardiri A, Consolo M, Mazzarino CM, Amoroso A, Neri S. Bruno CM, et al. Among authors: bertino g. Panminerva Med. 2009 Dec;51(4):191-6. Panminerva Med. 2009. PMID: 20195229

9

Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis.

Bertino G, Ardiri A, Boemi PM, Calvagno GS, Ruggeri IM, Speranza A, Santonocito MM, Ierna D, Bruno CM, Valenti M, Boemi R, Naimo S, Neri S. Bertino G, et al. Eur J Clin Pharmacol. 2010 Oct;66(10):1055-63. doi: 10.1007/s00228-010-0868-4. Epub 2010 Jul 22. Eur J Clin Pharmacol. 2010. PMID: 20652232 Free article. Clinical Trial.

10

A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patients with chronic hepatitis C treated with pegylated interferon α and ribavirin.

Neri S, Bertino G, Petralia A, Giancarlo C, Rizzotto A, Calvagno GS, Mauceri B, Abate G, Boemi P, Di Pino A, Ignaccolo L, Vadalà G, Misseri M, Maiorca D, Mastrosimone G, Judica A, Palermo F. Neri S, et al. Among authors: bertino g. J Clin Gastroenterol. 2010 Oct;44(9):e210-7. doi: 10.1097/MCG.0b013e3181d88af5. J Clin Gastroenterol. 2010. PMID: 20838237 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters